Johnson & Johnson’s blood cancer drug has received US FDA approval
![](https://4gi.tv/wp-content/uploads/2024/02/2202-ws-he1-1024x576.jpg)
The US Food and Drug Administration has approved Johnson & Johnson’s biweekly dose of Tecvayli blood cancer therapy. The approval allows the therapy to be used at a reduced dose of 1.5 milligrams per kilogram every fortnight in patients who have achieved and maintained a complete or better response for at least six months.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/07/2607-02.png)
‘The Kardashians’ renewed by Hulu for 20 more episodes
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env2.jpg)
Death toll from landslides in Ethiopia could rise to 500
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env1.jpg)
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env.jpg)
The Canadian wildfire has made its way to Jasper
July 26, 2024
LIVE STREAM